Literature DB >> 11270591

Heart rate variability and left ventricular diastolic function in patients with borderline hypertension with and without left ventricular hypertrophy.

G Martini1, F Rabbia, L Gastaldi, P Riva, M P Sibona, S Morra di Cella, L Chiandussi, F Veglio.   

Abstract

The relationships between heart rate variability (HRV), left ventricular mass and diastolic function in borderline hypertensive patients (BHT) were evaluated. 24 h Holter electrocardiogram (ECG) and blood pressure (BP) monitoring, M and 2 D echocardiogram and Doppler analysis in 42 BHT with and without left ventricular hypertrophy (LVH) and in 20 normotensive controls were assessed. From 24-h ECG, time domain indexes of HRV were calculated. Standard Deviation of all Cycles (SDNN) and Standard Deviation of the means of heart periods over five-minute intervals (SDANN) were significantly reduced in BHT with LVH but not in BHT without LVH. No significant differences of short-term variability measures were detectable, although a progressive decrease among control subjects and BHT with and without LVH was observed. Diastolic left ventricular compliance evaluated by early to late transmitral flow velocity ratio (E/A ratio) significantly declined from normotensive subjects to BHT with LVH. There was a significant positive correlation between E/A and SDNN and SDANN throughout all studied groups. This indicates that BHT with LVH has a reduced HRV compared to other groups. This impairment is probably related to left ventricular mass and left ventricular filling abnormalities.

Entities:  

Mesh:

Year:  2001        PMID: 11270591     DOI: 10.1081/ceh-100001199

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  6 in total

1.  Weekly Gemcitabine plus Fluorouracil-Folinic Acid Given Weekly for Two Days in Patients with Advanced Pancreatic Cancer : A Phase II Study.

Authors:  Aristides Polyzos; Nicholas Tsavaris; Christos Kosmas; Helen Gogas; George Koutinos; Nicholas I Nikiteas; Evangelos Felekouras; Gregory Kouraklis; Othon Papadopoulos; Antonios Papachristodoulou; Demetrios Stamatiadis; Michael Safioleas; George Nikou
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

2.  Cardiac and vascular consequences of pre-hypertension in youth.

Authors:  Elaine M Urbina; Philip R Khoury; Connie McCoy; Stephen R Daniels; Thomas R Kimball; Lawrence M Dolan
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04-21       Impact factor: 3.738

3.  Regression of left ventricular hypertrophy in diabetic nephropathy: loss of parasympathetic function predicts response to treatment.

Authors:  Larry A Weinrauch; Andrew J Berger; Doron Aronson; Ray E Gleason; Annette T Lee; John A D'Elia
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-05       Impact factor: 3.738

4.  Office and 24-hour heart rate and target organ damage in hypertensive patients.

Authors:  Angel García-García; Manuel A Gómez-Marcos; José I Recio-Rodríguez; Maria C Patino-Alonso; Emiliano Rodríguez-Sánchez; Cristina Agudo-Conde; Luis García-Ortiz
Journal:  BMC Cardiovasc Disord       Date:  2012-03-22       Impact factor: 2.298

Review 5.  Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Authors:  Oleg E Osadchii
Journal:  Heart Fail Rev       Date:  2007-03-27       Impact factor: 4.654

6.  Heart rate variability and target organ damage in hypertensive patients.

Authors:  Paolo Melillo; Raffaele Izzo; Nicola De Luca; Leandro Pecchia
Journal:  BMC Cardiovasc Disord       Date:  2012-11-15       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.